loader
Please Wait
Applying Filters...

Looking for (E,3R,5S)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid? Find Controlled & Modified Release used in (E,3R,5S)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 9,856Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Ideal Cures Pvt Ltd

02 14Kerry

03 1Kima Chemical

04 1Lonza Capsugel

05 2The Dow Chemical Company

06 3Vertellus

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

05

arrow
DCAT Week
Not Confirmed
arrow
DCAT Week
Not Confirmed

Brand : METHOCEL™

Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

arrow
blank

11

arrow
DCAT Week
Not Confirmed
arrow
DCAT Week
Not Confirmed

Brand : VCAPS® ENTERIC

Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

Technical Specs : Water content – less than 6%; Size #0

Grade : Oral

arrow
blank

14

arrow
DCAT Week
Not Confirmed
arrow
DCAT Week
Not Confirmed
blank